Reaction
Oropharyngeal Candidiasis reporting signals
As of the last recalculation, Oropharyngeal Candidiasis appears in 890 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is THEOPHYLLINE (PRR 33.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Theophylline | 16 | 33.1 | 33.2 |
| Theophylline Anhydrous | 17 | 32.7 | 32.7 |
| Fluticasone Furoate | 16 | 31.4 | 31.5 |
| Nystatin Ointment | 25 | 22.9 | 22.9 |
| Nystatin Cream | 25 | 22.9 | 22.9 |
| Nystatin | 25 | 22.0 | 22.0 |
| Bimekizumab | 18 | 20.2 | 20.2 |
| Abacavir Sulfate | 8 | 19.4 | 19.4 |
| Fluticasone Propionate And Salmeterol | 31 | 18.0 | 18.0 |
| Lapatinib | 10 | 15.2 | 15.2 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 25 | 14.5 | 14.5 |
| Ritonavir 100 Mg | 9 | 14.2 | 14.2 |
| Lamivudine | 18 | 13.9 | 13.9 |
| Vemurafenib | 7 | 13.7 | 13.7 |
| Lamivudine Oral | 14 | 13.1 | 13.1 |
| Atazanavir | 8 | 13.1 | 13.1 |
| Fluticasone Furoate And Vilanterol Trifenatate | 18 | 11.9 | 11.9 |
| Pertuzumab | 13 | 11.3 | 11.3 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 5 | 6.5 | 6.5 |